drugset / Trial / NCT05585983
INfluenza VaccInation To Mitigate typE 1 Diabetes
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In a multicenter, prospective, randomized, controlled clinical trial to compare influenza vaccination and placebo in sustaining β cell function in early type 1 diabetes mellitus.
Timeline
- Start
- 2022-12-14
- Primary completion
- 2026-05-01
- Completion
- 2027-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NITRAMINE | Vaccine | 15 ug | — |
| Subject | NITRAMINE | Vaccine | 0.5 ml | — |